Moyamoya Disease and Coronary Artery Disease (CAD): Hematological Associations, Pathophysiology, and Clinical Implications

By

Introduction

Moyamoya disease is a rare, progressive cerebrovascular disorder characterized by chronic narrowing (stenosis) of the internal carotid arteries and their major branches within the brain. As these vessels become occluded, a network of fragile collateral vessels forms to compensate for reduced blood flow. On angiographic imaging, this network resembles a “puff of smoke,” which is the meaning of the Japanese term moyamoya.

Coronary artery disease (CAD), by contrast, involves narrowing or blockage of the coronary arteries due to atherosclerosis. Although these diseases affect different vascular territories, growing evidence suggests that they may share underlying mechanisms, particularly involving endothelial dysfunction, inflammation, and hematological abnormalities.

Hematological Analysis and Associations

Moyamoya disease and Moyamoya syndrome (secondary forms associated with other conditions) are frequently linked to hematological disorders that either impair oxygen delivery or promote abnormal clotting. These factors may contribute to progressive vascular stenosis and ischemia.

Hemoglobinopathies and Chronic Anemia

One of the most well-established associations is with Sickle Cell Disease, particularly in pediatric populations. In this condition, abnormal hemoglobin leads to red blood cell deformation, vaso-occlusion, and chronic hemolysis. These processes damage the vascular endothelium and significantly increase the risk of stroke and Moyamoya syndrome.

Other hemoglobinopathies, including thalassemia and rare variants such as Hemoglobin Fairfax, have also been linked to Moyamoya. Additionally, severe chronic iron deficiency anemia can reduce oxygen-carrying capacity, contributing to cerebral ischemia and potentially triggering compensatory vascular remodeling.

Hemoglobinopathies Disorders

Autoimmune conditions such as Systemic lupus erythematosus (SLE) are associated with chronic inflammation and vascular injury. These processes can promote endothelial dysfunction and accelerate vascular narrowing.

Similarly, Antiphospholipid syndrome is characterized by a hypercoagulable state, leading to recurrent thrombosis in both arterial and venous systems. This increases the likelihood of ischemic events and may contribute to the development of Moyamoya syndrome.

Prothrombotic and Inflammatory States

Across these conditions, a common theme is the presence of a prothrombotic state combined with chronic inflammation. These factors can damage the vascular endothelium, impair nitric oxide signaling, and promote smooth muscle proliferation—key mechanisms in both cerebral and coronary artery disease.

Biomarkers and Disease Activity

Hematological studies in active Moyamoya disease often reveal elevated circulating levels of growth factors involved in angiogenesis and vascular remodeling. These include:

Vascular endothelial growth factor (VEGF)

Matrix metalloproteinase-9 (MMP-9)

Basic fibroblast growth factor (bFGF)

These markers reflect an ongoing attempt by the body to compensate for reduced cerebral perfusion by promoting new vessel formation. However, the resulting collateral vessels are often structurally weak and prone to rupture. 

Clinical Presentation

The clinical manifestations of Moyamoya disease vary significantly by age.

Children

Children most commonly present with transient ischemic attacks (TIAs) or ischemic strokes. These episodes are often triggered by hyperventilation, such as during crying or physical exertion, which reduces carbon dioxide levels and causes cerebral vasoconstriction.

Adults

Adults are more likely to present with intracerebral hemorrhage due to rupture of fragile collateral vessels. Ischemic events can also occur but are less dominant compared to pediatric cases.

 

Cardiovascular Associations and Comorbidities

Although Moyamoya primarily affects cerebral vessels, systemic vascular involvement is increasingly recognized.

Congenital Heart Defects

Moyamoya vasculopathy has been reported in association with congenital heart defects such as aortic coarctation. These structural abnormalities may contribute to altered hemodynamics and increased vascular stress.

Cardiovascular Comorbidities

Patients with Moyamoya may also exhibit:

Arterial hypertension

Left ventricular hypertrophy

Increased risk of cerebrovascular and cardiovascular events

These findings suggest a broader vascular pathology extending beyond the brain.

 

Endothelial Dysfunction as a Unifying Mechanism

Endothelial dysfunction plays a central role in both Moyamoya disease and CAD. The endothelium regulates vascular tone, blood flow, and coagulation. When dysfunctional, it promotes:

Vasoconstriction

Inflammation

Thrombosis

Abnormal vascular remodeling

These processes contribute to arterial narrowing in both cerebral and coronary circulations. Chronic inflammatory states, oxidative stress, and hematological abnormalities further exacerbate endothelial injury.

Additional Associated Conditions

Thyroid Dysfunction

Graves' disease and other forms of thyrotoxicosis have been associated with Moyamoya syndrome. Elevated thyroid hormone levels increase metabolic demand and hemodynamic stress, which may accelerate vascular changes.

Common comorbidities include:

Tachycardia

Atrial fibrillation

Weight loss

Osteoporosis

Systemic Features

Across associated conditions, patients may exhibit:

Chronic inflammation

Endothelial dysfunction

Hypercoagulability

These overlapping features reinforce the concept of Moyamoya as part of a broader systemic vascular disorder in some cases.

Coronary Artery Disease: The Most Common Type

The most common form of CAD is obstructive coronary artery disease. In this condition, plaque gradually accumulates within the coronary arteries, leading to progressive narrowing and reduced blood flow to the heart muscle. This process can ultimately result in angina, myocardial infarction, or heart failure.

Endothelial dysfunction is a key early event in atherosclerosis, linking CAD pathogenesis to mechanisms also observed in Moyamoya disease.

Conclusion

Moyamoya disease and coronary artery disease, while traditionally considered separate entities, share important pathophysiological features. Hematological abnormalities, chronic inflammation, and endothelial dysfunction provide a plausible link between cerebral and coronary vascular pathology.

Understanding these shared mechanisms is essential for recognizing potential systemic involvement, improving diagnostic evaluation, and guiding comprehensive management strategies in affected patients.

References:

Endovascular profiles linked to neutrophil activation in children and young adults with long COVID https://pubmed.ncbi.nlm.nih.gov/42020802/

Endothelial Dysfunction: What is endothelial dysfunction? https://my.clevelandclinic.org/health/diseases/23230-endothelial-dysfunction

Coronary Heart Disease in Moyamoya Disease: Are They Concomitant or Coincidence? https://pmc.ncbi.nlm.nih.gov/articles/PMC4366969/

Moyamoya Disease Associated With Hemoglobin Fairfax and Beta-Thalassemia
https://www.sciencedirect.com/science/article/abs/pii/S0887899407004687

Endothelial Dysfunction https://my.clevelandclinic.org/health/diseases/23230-endothelial-dysfunction

Pathophysiology, diagnosis, and treatment https://di.aerzteblatt.de/int/archive/article/247801

Moyamoya Disease https://www.ncbi.nlm.nih.gov/books/NBK535455/

 

© 2000-2030 Sieglinde W. Alexander. All writings by Sieglinde W. Alexander have a five-year copyright. Library of Congress Card Number: LCN 00-192742 ISBN: 0-9703195-0-9   

Comments

Post a Comment

Popular posts from this blog

Schnitzler Syndrome: A Rare Autoinflammatory Disorder

By
Schnitzler syndrome is a rare, chronic autoinflammatory disease characterized by chronic urticaria (hives), recurrent fever, joint pain, and monoclonal gammopathy (abnormal proteins in the blood). First described by Dr. Liliane Schnitzler in 1972 , this condition is often misdiagnosed, leading to years of untreated symptoms before a correct diagnosis is made. The case report, " A 58-Year-Old Woman With Urticaria, Fever, and Joint Pain " , describes a case that closely aligns with my own experience with this challenging disorder. Key Features of Schnitzler Syndrome Schnitzler syndrome presents with a characteristic set of symptoms, though not all patients experience them in the same way: Chronic Urticaria (Hives) – Persistent, non-itchy or mildly itchy red patches that do not respond to antihistamines. Monoclonal Gammopathy (IgM or IgG type) – Abnormal monoclonal immunoglobulin detected in the blood (most commonly IgM ). Recurrent Fever – Unexplained fever episodes, often...
Read more

Acute Flaccid Myelitis (AFM): Understanding the “Polio-like” Illness Affecting the Spinal Cord

By
Acute flaccid myelitis (AFM) is a rare but serious neurological disorder that primarily affects children and results in sudden weakness or paralysis in the limbs. Often referred to as a “polio-like” illness, AFM has drawn growing attention over the past decade due to its similarities with poliomyelitis and its seasonal spikes in reported cases. While AFM remains uncommon, its potential severity—and the uncertainty surrounding its causes—make it an important condition for clinicians, parents, and public health officials to understand. What Is Acute Flaccid Myelitis? AFM is a condition that affects the gray matter of the spinal cord , where it damages motor neurons responsible for muscle movement. This leads to acute, flaccid paralysis , meaning muscles become limp and weak, often without warning. The condition can progress rapidly, and in some cases, the weakness can become long-lasting or even permanent. Although its symptoms resemble those of poliovirus infection, AFM is not cau...
Read more

Very Long-Chain Fatty Acids (VLCFAs) X-ALD and Spinal Muscular Atrophy (SMA): Exploring the Connection

By
Image
Introduction: White Brain Matter, VLCFAs, and X-ALD X-linked Adrenoleukodystrophy (X-ALD) is a rare inherited metabolic disorder and a major cause of progressive neurodegeneration in children—sometimes referred to as “childhood dementia.” Across related conditions, prevalence can range from approximately 1 in 2,000 to 1 in 500,000 newborns. Among its forms, childhood cerebral X-ALD is the most severe, marked by rapid inflammatory demyelination in the brain and often fatal outcomes if not treated early. At the core of X-ALD is a disruption in the metabolism of Very Long-Chain Fatty Acids (VLCFAs). Normally, these fatty acids are broken down in peroxisomes—specialized structures within cells that help maintain metabolic balance. In X-ALD, a mutation in the ABCD1 gene impairs this function, causing VLCFAs to accumulate, particularly in the white matter of the brain, spinal cord, and adrenal glands. This accumulation leads to demyelination, adrenal insufficiency (Addison’s disease), an...
Read more

Dysferlin Protein: Key Roles, Genetic Locations

By
Image
The purpose of this article is to share and discuss the details of a new discovery, which is highlighted within: CRISPR-Cas9: A Breakthrough Tool to Repair the DYSF Gene The dysferlin protein plays an essential role in maintaining the integrity of muscle cell membranes, particularly in tissues that endure significant mechanical stress, such as skeletal and cardiac muscles . Encoded by the DYSF gene , dysferlin is indispensable for repairing damaged cell membranes after injury caused by muscle contraction or external forces. This article explores the main locations where dysferlin is produced, its role in muscle repair, and supportive nutritional and therapeutic strategies for individuals with dysferlin deficiency, such as those affected by dysferlinopathies (e.g., Limb-Girdle Muscular Dystrophy Type 2B or Miyoshi Myopathy). Currently, there is no definitive answer as to why the severity of dysferlin protein expression or depletion varies. Do pathogens play a role in the methylation o...
Read more

Toxic Skin Condition Post-mRNA COVID-19 Vaccination

By
Image
Important update: My experiences have now been formally verified following several years of dismissal. Vasculitis syndromes: the pathogenic roles of COVID-19 and related vaccinations https://link.springer.com/article/10.1186/s12985-025-03032-x  ----------------------------------------- Identifying Severe Skin Conditions Post-Vaccination Following administration of the BioNTech mRNA vaccine, a small subset of individuals may develop severe and complex reactions. These reactions are often misdiagnosed or misunderstood due to their rarity and diverse presentation. This essay examines a case characterized by severe skin conditions, systemic symptoms, and complications such as hypercalcemia and crystal formation. It highlights the need for accurate diagnosis, holistic management, and increased awareness of these rare but significant vaccine-related adverse events. Initial Symptoms and Misdiagnoses Severe symptoms began shortly after the first dose of the BioNTech vaccine, initially pres...
Read more

Is ME CFS connected to Spinal Muscular Atrophy (SMA) or Post Polio?

By
Today, I understand why Spinal Muscular Atrophy (SMA) received little attention, particularly in the mid-50s. This complex and debilitating genetic illness was poorly understood, and patients' symptoms were often minimized or even dismissed. For more information, please visit the Spinal Muscular Atrophy (SMA) page on MalaCards . Even now, many neurologists lack detailed knowledge of SMA, and comprehensive examinations mentioned in research are rarely pursued. In 2008, while investigating permanent adrenal insufficiency, an MRI ordered by my endocrinologist unexpectedly revealed Chiari Malformation II. However, surgery in 2009 brought no improvement. In 2010, a DNA test showed a genetic marker in the ACTN3 gene: https://www.malacards.org/search/results?q=ACTN3%20gene%20and%20Spinal%20Muscular%20Atrophy%20(SMA) A 2015 MRI revealed ankylosing spondylitis, multiple Tarlov cysts, stenosis at L4 and L5, spinal canal narrowing, and widespread degenerative changes. Surgery on L4 and L5 ...
Read more

Polio and Post-Polio Syndrome (PPS): Summary and Key Insights

By
Image
  In the human body, poliovirus can survive and replicate for varying durations depending on the phase of infection and the individual's immune response: Incubation Period : After entering the body, poliovirus can begin replicating in the throat and intestines within a few hours. The typical incubation period lasts 7 to 10 days (but can range from 3 to 35 days ), during which the virus is actively multiplying. Shedding in Feces : Even after symptoms have resolved or in asymptomatic cases, poliovirus can be excreted in the feces for an extended period. In most individuals, the virus is shed in feces for 4 to 8 weeks after infection. In rare cases, especially in individuals with compromised immune systems, the virus may persist in the gut and be shed for months or even years (a condition called chronic excretion ). Bloodstream : If the virus enters the bloodstream and causes viremia, it may persist there for a few days before being cleared by the immune system or progressing to ...
Read more

Cytokine Storm, Mast Cell Activation Syndrome (MCAS), Endothelial Dysfunction and microclots/thrombosis?

By
Update: New Research Builds on Previous Findings Cytokine Storms in COVID-19, Hemophagocytic Lymphohistiocytosis, and CAR-T Therapy https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2832234?utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jamanetworkopen&utm_content=wklyforyou&utm_term=040925&adv= Conclusions: This recent cohort study builds upon earlier work by identifying COVID-related cytokine storm (COVID-CS) through common inflammation markers and comparing it with two other cytokine storm (CS) conditions: malignancy-associated hemophagocytic lymphohistiocytosis (MN-HLH) and CAR-T–associated cytokine release syndrome (CAR-T CRS) . Among the three groups, patients treated with CAR-T therapy showed the highest survival rates , in contrast to those with COVID-CS and MN-HLH. Interestingly, the study found that CAR-T CRS and COVID-CS share similar cytokine activation pathways , suggesting a comparable immune response mechanism. In c...
Read more

Introduction to Adenosine and Tachycardia

By
What is Adenosine? Adenosine is a chemical found in human cells, existing in three forms: adenosine, adenosine monophosphate (AMP), and adenosine triphosphate (ATP). Adenosine is a chemical found in the body that plays many roles, including influencing heart rate and promoting sleep and relaxation. It is also used as a medication to manage certain types of tachycardia, particularly supraventricular tachycardia. Adenosine works by slowing the heart rate through its action on the cardiac tissue. Adenosine production in the body occurs through multiple pathways: Phosphorylation of Adenine: Adenine can be directly phosphorylated to form AMP (adenosine monophosphate), which is then converted to ATP, ADP, and finally adenosine through dephosphorylation reactions. Breakdown of ATP: Adenosine is primarily formed in the body through the breakdown of ATP, which releases energy. ATP can be dephosphorylated stepwise through the action of various enzymes: ATP is first converted to ADP (adeno...
Read more

Impact of Penicillium on Muscle and Lung Function: What Healthcare Professionals Should Know

By
Image
Introduction While symbiotic relationships between viruses and bacteria have been documented, the possibility of a symbiosis between COVID-19 (SARS-CoV-2) and common fungal genera such as Penicillium , Aspergillus , and Trichoderma remains unexplored. This gap in research presents a potential area of interest for understanding novel microbial interactions and their implications for human health. Symbiosis Between Viruses and Bacteria – A Fascinating Partnership in the Microbial World https://swaresearch.blogspot.com/2025/07/symbiosis-between-viruses-and-bacteria.html When viruses, bacteria, or fungi—such as Penicillium —enter a host, they can trigger a range of immune responses and physiological disruptions.  Penicillium molds do not directly produce autoantibodies. However, exposure to Penicillium mold and its mycotoxins can trigger an immune response that may lead to the production of IgG antibodies , including those that could be reactive against the body's own tissues ,...
Read more